Cited investment memo and model. Ready for analyst review.
Enter a company and deal context. Steppes researches public filings or private-company registry data and produces a cited first-draft investment memo, working financial model, and material-assumption review. Add authorized company materials or expert evidence when available.
REQUEST FREE ACCESS →Purpose-built for due diligence workflows.
Steppes uses current frontier models, live web research, section-specific generation, and a fixed evidence schema. Claims remain linked to sources and material assumptions remain reviewable. Outputs are first drafts for analyst verification.
One workflow from target selection to export.
Customer materials remain within your gated workspace.
Customer materials are used only to generate, save, edit, and export your requested analysis. Each workspace is strictly separated by access code. Materials are never added to a shared Steppes.ai catalog, exposed to other customers, resold, or pooled.
Model providers process requests only to generate the requested output. Provider storage is disabled, and customer content is not used for model training or secondary use. Processing is covered by contractual data-protection terms, including the EU Standard Contractual Clauses.
Rights-cleared expert evidence inside the same analysis.
Steppes is seeking selected expert-network partners for a rights-cleared transcript library. The intended listing includes the expert's role, company context, region, call duration, diligence angle, and a redacted preview. Rights, consent, compliance, pricing, and the expert relationship remain with the participating network.
Transcript search retrieves evidence. Steppes applies it to the memo and model.
Transcript libraries help users find relevant calls. Steppes is designed to connect that evidence to cited memo sections, model assumptions, and unresolved diligence questions.
Three complimentary analyses.
Early access includes three complimentary analyses on public companies, exited investments, dead deals, or anonymized cases. No payment details or confidential documents are required. Candid feedback on the memo, workbook, and assumptions is welcome. Transcript access remains subject to partner availability and agreed licensing terms.